This topic contains a solution. Click here to go to the answer

Author Question: The receptors upon which delta-9-THC acts have been shown to be a. noradrenergic b. ... (Read 34 times)

Mr. Wonderful

  • Hero Member
  • *****
  • Posts: 866
The receptors upon which delta-9-THC acts have been shown to be
 
  a. noradrenergic
  b. dopaminergic
  c. serotonergic
  d. none of these

Question 2

Marijuana is most likely going to increase
 
  a. blood pressure
  b. heart rate
  c. pressure in the eyeball
  d. all of these



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Carissamariew

  • Sr. Member
  • ****
  • Posts: 359
Answer to Question 1

d

Answer to Question 2

b




Mr. Wonderful

  • Member
  • Posts: 866
Reply 2 on: Jun 22, 2018
YES! Correct, THANKS for helping me on my review


phuda

  • Member
  • Posts: 348
Reply 3 on: Yesterday
Gracias!

 

Did you know?

A serious new warning has been established for pregnant women against taking ACE inhibitors during pregnancy. In the study, the risk of major birth defects in children whose mothers took ACE inhibitors during the first trimester was nearly three times higher than in children whose mothers didn't take ACE inhibitors. Physicians can prescribe alternative medications for pregnant women who have symptoms of high blood pressure.

Did you know?

Asthma cases in Americans are about 75% higher today than they were in 1980.

Did you know?

The National Institutes of Health have supported research into acupuncture. This has shown that acupuncture significantly reduced pain associated with osteoarthritis of the knee, when used as a complement to conventional therapies.

Did you know?

All adults should have their cholesterol levels checked once every 5 years. During 2009–2010, 69.4% of Americans age 20 and older reported having their cholesterol checked within the last five years.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library